Proliferative changes of renal arteriolar walls induced by administration of angiotensin II receptor blocker are frequent in juvenile rats

被引:5
作者
Nagai, Yohko [1 ,2 ]
Nakanishi, Kazushige [2 ]
Akimoto, Tatsuo [2 ]
Yamanaka, Nobuaki [1 ]
机构
[1] Tokyo Kidney Res Inst, Tokyo 1130023, Japan
[2] Toho Univ, Fac Med, Dept Gen Med & Emergency Care, Tokyo, Japan
关键词
Renal pathology; afferent arteriole; smooth muscle cell hyperplasia; angiotensin II receptor blocker; juvenile; SMOOTH-MUSCLE-CELLS; ESSENTIAL-HYPERTENSION; ANTIHYPERTENSIVE TREATMENT; ENDOTHELIAL DYSFUNCTION; JUXTAGLOMERULAR CELLS; ANTAGONIST; HYPERTROPHY; RENIN; DIFFERENTIATION; HYPERPLASIA;
D O I
10.1177/1470320313502105
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction: Our previous study of angiotensin II receptor blocker (ARB) administration in rats induced unusual proliferative changes of smooth muscle cells in renal arteriolar walls. The present study examined if the incidence of the changes depended on the rats' age, and how long it would take to find changes. Materials and methods: Six-week-old (juvenile spontaneous hypertensive rats (SHRs)+ARB group, n=15) and 20-week-old (adult SHRs+ARB group, n=10) male SHRs were fed a standard diet (0.4% NaCl) containing valsartan (10 mg/kg/day; Novartis Co.). Fifteen age-matched SHRs were studied as controls. After 4, 8, and 12 weeks, the rat kidneys were examined under light and electron microscopes and through immunohistochemical studies. Results: Extremely concentric proliferative changes in afferent arteriolar walls were frequently observed in the juvenile SHR+ARB group compared to the adult SHR+ARB group (48.76.8% vs 19.3 +/- 6.9%; p=0.0307) at the 12(th) week. Increased renin expression and arteriolar changes were found from the 4(th) week in the juvenile SHR+ARB group. Conclusion: This study indicates that ARB administration induces unusual proliferative changes and a marked renin-producing cell increase in afferent arterioles more frequently in juveniles than adult rats. It is suggested that the treatment of ARB in juveniles might have a higher risk of changes in renal afferent arterioles.
引用
收藏
页码:440 / 449
页数:10
相关论文
共 50 条
  • [21] Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice
    Zhu, Ye
    Li, Ze-Liang
    Ding, Ao
    Yang, Hui
    Zhu, Wei-Ping
    Cui, Tong-Xia
    Zhang, Hui-Tao
    Zhang, Hua
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 3657 - 3667
  • [22] Reduced sensitivity of the renal vasculature to angiotensin II in young rats: the role of the angiotensin type 2 receptor
    Brown, Russell D.
    Hilliard, Lucinda M.
    Mirabito, Katrina M.
    Firth, Laura C.
    Moritz, Karen M.
    Evans, Roger G.
    Denton, Kate M.
    PEDIATRIC RESEARCH, 2014, 76 (05) : 448 - 452
  • [23] Platelet Activation in Essential Hypertension During Exercise: Pre- and Post-Treatment Changes With an Angiotensin II Receptor Blocker
    Gkaliagkousi, Eugenia
    Gavriilaki, Eleni
    Yiannaki, Efi
    Markala, Dimitra
    Papadopoulos, Nikolaos
    Triantafyllou, Areti
    Anyfanti, Panagiota
    Petidis, Konstantinos
    Garypidou, Vasileia
    Doumas, Michael
    Ferro, Albert
    Douma, Stella
    AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (04) : 571 - 578
  • [24] Effect of systemic administration of valsartan, an angiotensin II type 1 receptor blocker, on retinal circulation in healthy humans
    Nagaoka, T.
    Takahashi, A.
    Sato, E.
    Yokota, H.
    Izumi, N.
    Yoshida, A.
    EYE, 2009, 23 (06) : 1491 - 1492
  • [25] Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression
    He, Ming
    Zhang, Lin
    Shao, Ying
    Xue, Hong
    Zhou, Li
    Wang, Xiao-Fang
    Yu, Chen
    Yao, Tai
    Lu, Li-Min
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 315 (1-2) : 188 - 194
  • [26] Low-grade albuminuria reduction with angiotensin II type 1 receptor blocker in renal transplant recipients
    Uchida, Junji
    Machida, Yuichi
    Iwai, Tomoaki
    Iguchi, Taro
    Kamada, Yoshiko
    Naganuma, Toshihide
    Kumada, Norihiko
    Kim, Taku
    Kawashima, Hidenori
    Nakatani, Tatsuya
    JOURNAL OF NEPHROLOGY, 2011, 24 (04) : 515 - 521
  • [27] THE RENIN-ANGIOTENSIN SYSTEM AND VOLUME OVERLOAD-INDUCED CARDIAC-HYPERTROPHY IN RATS - EFFECTS OF ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR VERSUS ANGIOTENSIN-II RECEPTOR BLOCKER
    RUZICKA, M
    YUAN, BX
    HARMSEN, E
    LEENEN, FHH
    CIRCULATION, 1993, 87 (03) : 921 - 930
  • [28] Renal transplantation increases angiotensin II receptor-mediated vascular contractility associated with changes of epigenetic mechanisms
    Zhao, Yakun
    Zhu, Qingguo
    Sun, Shiping
    Qiu, Yu
    Li, Jingquan
    Liu, Wei
    Yuan, Gangjun
    Ma, Hua
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (04) : 2375 - 2388
  • [29] RENIN AND ANGIOTENSIN-II RECEPTOR GENE-EXPRESSION IN KIDNEYS OF RENAL HYPERTENSIVE RATS
    HAEFLIGER, JA
    BERGONZELLI, G
    WAEBER, G
    AUBERT, JF
    NUSSBERGER, J
    GAVRAS, H
    NICOD, P
    WAEBER, B
    HYPERTENSION, 1995, 26 (05) : 733 - 737
  • [30] Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats
    Hasegawa, Goji
    Fukui, Michiaki
    Hosoda, Hiroko
    Asano, Mai
    Harusato, Ichiko
    Tanaka, Muhei
    Shiraishi, Emi
    Senmaru, Takashi
    Sakabe, Kazumi
    Yamasaki, Masahiro
    Kitawaki, Jo
    Fujinami, Aya
    Ohta, Mitsuhiro
    Obayashi, Hiroshi
    Nakamura, Naoto
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 605 (1-3) : 164 - 169